SOLRIKITUG: A NEW ANTI-TSLP PROTEIN FOR THERAPEUTIC PROMISE

Solrikitug, a newly identified monoclonal immunoglobulin , represents a exciting therapeutic option for allergic diseases . Targeting Thymic Stromal Lymphopoietin (TSLP), a key cytokine implicated in initiating inflammation , Solrikitug exhibits potent ability to neutralize TSLP function . Precli